odronextamab,mosunetuzumab,epcoritamab
Genmab,Abbvie,Regeneron,Roche
['lymphoma', 'follicular']
another big day for bites in r/r follicular #lymphoma at #17icml. high activity with crs &gt;60% and good durability. combination with r2 looks safe, but can we safely combine with other agents as well? stay tuned! 
Clinician and researcher specializing in lymphoma. Tweets are my own.